Cargando…

Genes Regulated by HPV 16 E6 and High Expression of NFX1-123 in Cervical Cancers

PURPOSE: High-risk human papillomaviruses (HR HPV) cause cervical cancer, and in these cancers, HPV type 16 is the most common HR type. The HR viral oncogenes E6 and E7 partner with cellular proteins to drive cancer and modulate immune pathways; previously, we demonstrated in keratinocytes that HPV...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chintala, Sreenivasulu, Levan, Justine, Robinson, Kristin, Quist, Kevin, Katzenellenbogen, Rachel A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7326398/ https://www.ncbi.nlm.nih.gov/pubmed/32617009 http://dx.doi.org/10.2147/OTT.S251926

Ejemplares similares

Cervical Cancer Development: Implications of HPV16 E6E7-NFX1-123 Regulated Genes
por: Quist, Kevin M., et al.
Publicado: (2021)

Human papillomavirus type 16 E6 and NFX1-123 mislocalize immune signaling proteins and downregulate immune gene expression in keratinocytes
por: Levan, Justine, et al.
Publicado: (2017)

NFX1, Its Isoforms and Roles in Biology, Disease and Cancer
por: Chintala, Sreenivasulu, et al.
Publicado: (2021)

Post-Transcriptional Gene Regulation by HPV 16E6 and Its Host Protein Partners
por: Billingsley, Caylin L., et al.
Publicado: (2022)

nfxB as a Novel Target for Analysis of Mutation Spectra in Pseudomonas aeruginosa
por: Monti, Mariela R., et al.
Publicado: (2013)

Deep Sequencing of HPV16 E6 Region Reveals Unique Mutation Pattern of HPV16 and Predicts Cervical Cancer
por: Ai, Wenchao, et al.
Publicado: (2022)

Role of HPV16 E1 in cervical carcinogenesis
por: Baedyananda, Fern, et al.
Publicado: (2022)

HPV16 E6 Promotes the Progression of HPV Infection-Associated Cervical Cancer by Upregulating Glucose-6-Phosphate Dehydrogenase Expression
por: Chang, Ye-Fei, et al.
Publicado: (2021)

KSHV co-infection down-regulates HPV16 E6 and E7 from cervical cancer cells
por: Dai, Lu, et al.
Publicado: (2017)

HPV E6, E6AP and cervical cancer
por: Beaudenon, Sylvie, et al.
Publicado: (2008)

Blockade of Axl signaling ameliorates HPV16E6-mediated tumorigenecity of cervical cancer
por: Lee, Eun-Hee, et al.
Publicado: (2017)

IRF-1 Inhibits Angiogenic Activity of HPV16 E6 Oncoprotein in Cervical Cancer
por: Rho, Seung Bae, et al.
Publicado: (2020)

Highly potent and specific siRNAs against E6 or E7 genes of HPV16- or HPV18-infected cervical cancers
por: Chang, J T-C, et al.
Publicado: (2010)

Association of cervical carcinogenesis risk with HPV16 E6 and E7 variants in the Taizhou area, China
por: Dai, Mei-Zhen, et al.
Publicado: (2021)

NFX1-LIKE2 (NFXL2) Suppresses Abscisic Acid Accumulation and Stomatal Closure in Arabidopsis thaliana
por: Lisso, Janina, et al.
Publicado: (2011)

A novel HPV16 E7-affitoxin for targeted therapy of HPV16-induced human cervical cancer
por: Jiang, Pengfei, et al.
Publicado: (2018)

Telomerase Induction in HPV Infection and Oncogenesis
por: Katzenellenbogen, Rachel
Publicado: (2017)

HPV16 E6 Controls the Gap Junction Protein Cx43 in Cervical Tumour Cells
por: Sun, Peng, et al.
Publicado: (2015)

MiR-187 overexpression inhibits cervical cancer progression by targeting HPV16 E6
por: Lin, Mao, et al.
Publicado: (2017)

Expression of Yin Yang 1 in cervical cancer and its correlation with E-cadherin expression and HPV16 E6
por: Wang, Wanxue, et al.
Publicado: (2018)

HPV16 E6 regulates the proliferation, invasion, and apoptosis of cervical cancer cells by downregulating miR-504
por: Zhang, Lina, et al.
Publicado: (2020)

HPV16 E6 upregulates Aurora A expression
por: Guo, Yi, et al.
Publicado: (2016)

Viral E6 is overexpressed via high viral load in invasive cervical cancer with episomal HPV16
por: Hong, Die, et al.
Publicado: (2017)

Roles of the PDZ‐binding motif of HPV 16 E6 protein in oncogenic transformation of human cervical keratinocytes
por: Yoshimatsu, Yuki, et al.
Publicado: (2017)

Novel Affibody Molecules Targeting the HPV16 E6 Oncoprotein Inhibited the Proliferation of Cervical Cancer Cells
por: Zhu, Jinshun, et al.
Publicado: (2021)

HPV DNA methylation at the early promoter and E1/E2 integrity: A comparison between HPV16, HPV18 and HPV45 in cervical cancer
por: Amaro-Filho, Sérgio Menezes, et al.
Publicado: (2018)

HPV16-E6/E7 Oncogene Mutation and p53 Expression among Indonesian Women with Cervical Cancer
por: Mahendra, I Nyoman Bayu, et al.
Publicado: (2022)

E6/E7 and E6(*) From HPV16 and HPV18 Upregulate IL-6 Expression Independently of p53 in Keratinocytes
por: Artaza-Irigaray, Cristina, et al.
Publicado: (2019)

HPV16 E6 seropositivity among cancer-free men with oral, anal or genital HPV16 infection
por: Beachler, Daniel C., et al.
Publicado: (2016)

hnRNP E1 Regulates HPV16 Oncogene Expression and Inhibits Cervical Cancerization
por: Song, Li, et al.
Publicado: (2022)

Establishment of immunoassay for detecting HPV16 E6 and E7 RNA
por: Ding, Sen, et al.
Publicado: (2015)

Anti-HPV16 Antibody Titers Prior to an Incident Cervical HPV16/31 Infection
por: Gradissimo, Ana, et al.
Publicado: (2021)

Phylogeny and Classification of Human Papillomavirus (HPV)16 and HPV18 Variants Based on E6 and L1 genes in Tunisian Women with Cervical Lesions
por: Jendoubi-Ferchichi, Mouna, et al.
Publicado: (2018)

Differential localization of HPV16 E6 splice products with E6-associated protein
por: Vaeteewoottacharn, Kulthida, et al.
Publicado: (2005)

RIPOR2 Expression Decreased by HPV-16 E6 and E7 Oncoproteins: An Opportunity in the Search for Prognostic Biomarkers in Cervical Cancer
por: Olmedo-Nieva, Leslie, et al.
Publicado: (2022)

Uneven distribution of HPV 16 E6 prototype and variant (L83V) oncoprotein in cervical neoplastic lesions
por: Andersson, S, et al.
Publicado: (2000)

Human Papillomavirus (HPV) 16 E6 Variants in Tonsillar Cancer in Comparison to Those in Cervical Cancer in Stockholm, Sweden
por: Du, Juan, et al.
Publicado: (2012)

Analysis of ROC: The value of HPV16 E6 protein in the diagnosis of early stage cervical carcinoma and precancerous lesions
por: Sun, Li, et al.
Publicado: (2016)

Nimotuzumab Combined With Irradiation Enhances the Inhibition to the HPV16 E6-Promoted Growth of Cervical Squamous Cell Carcinoma
por: Xu, Zhonghua, et al.
Publicado: (2020)

HPV16 E6-specific T cell response and HLA-A alleles are related to the prognosis of patients with cervical cancer
por: Cai, Hongchao, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_v4hpd0ttp7um219e8276jlrgot